semaglutide for diabetes type 1 Tirzepatide vs. Semaglutide: What You Should Know FDA Clears Semaglutide For Cardiac

Patients with type 2 diabetes who want an oral semaglutide option currently have Rybelsus (7 mg or 14 mg), which is approved for glycemic management though at lower doses and with a different primary indication

Appreciate you Bryan

I have had acid reflux, burping, vomiting, constipation, headache, and dizziness

New England Journal of Medicine (NEJM), 2023 Phase 2 Trial Results JAMA, 2024 Metabolic Effects of Retatrutide Cell Metabolism, 2024 Triple Agonist Mechanism Review American Diabetes Association (ADA) Scientific Sessions 2023 Eli Lilly Clinical Pipeline Report 2024

For the first time, diabetic spend is flattening faster than non-diabetic spend, a reversal of the previous pattern where diabetes costs outpaced everything else by 2x